Must have hemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.
Hgb ? 10 g/dL
Hemoglobin (Hgb) >= 8 g/dL (with or without transfusion support)
Patients with Hgb > 8.0 g/dl (transfusion allowed)
Hgb < 10 g/dL
Hemoglobin (HGB) > 8.0 gm/dL (patients may be transfused to achieve this HGB level);
Additional Laboratory Requirements ANC ?1.0 x 109/L Hgb ?8 g/dL(transfusion permitted) Platelet count ?50.0 x 109/L
Hgb > 8.0 (transfusion allowed)
Hemoglobin (HgB) > 9 g/dL. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.
Hemoglobin (Hgb) >= 9 g/dL (with/without transfusion)
Hgb ? 9 g/dL
Hgb > 8.0 (transfusion allowed)
Hemoglobin (Hgb) < 8 mg/dl, per PI discretion if thought to be related to underlying myeloma
Hemoglobin (Hgb) >= 9 g/dL (more than 48 hours post-completion of blood transfusion)
Hemoglobin (Hgb) >= 9 g/dL (in absence of blood transfusion).
Within 4 weeks of day 1: Hemoglobin (HgB) >= 10.0 gr/dL independent of transfusion
Hemoglobin (Hgb) ? 9 g/dL obtained ? 14 days prior to randomization; patient may receive transfusion as needed
Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L without (w/o) transfusion within 7 days of assessment.
Hemoglobin (Hgb) >= 9 g/dL; (last transfusion cannot be within 7 days of trial initiation)
Hgb >= 10 g/dL ((within 16 days before starting therapy)
HGB of > 10 g/L
PART 2 GROUP 2A INCLUSION CRITERIA: Hgb >= 8 g/dL (may receive RBC transfusion)
PART 2 GROUP 3 INCLUSION CRITERIA: Hgb >= 8 g/dL (may receive RBC transfusion)
EXCLUSION CRITERIA FOR PATIENTS WITH NSCLC OR TNBC (COHORT B): Hemoglobin (Hgb) < 9 mg/dl (transfusion permitted to achieve this)
EXCLUSION CRITERIA FOR TNBC: Hgb < 9 mg/dl (transfusion permitted to achieve this)
PRIOR TO CELL PROCUREMENT: Hemoglobin (Hgb) ? 8.0 g/dL (transfusion independent for 2 weeks prior to enrollment)
Hgb ? 9 g/dL
Within 14 days prior to study entry: Hemoglobin (Hgb) > 9.0 g/dL (with or without transfusion)
TREATMENT: Hgb > 8.0 (transfusion allowed)
Hgb > 8.0
Hemoglobin (HgB) > 9.0 g/dL; NOTE: subjects may not have had a transfusion within 7 days of registration
Within 14 days of study drug(s) initiation: Hemoglobin (Hgb) >= 10 g/dL with no blood transfusion in the past 14 days.
EXCLUSION CRITERIA FOR TREATMENT: Hgb less than or equal to 8 g/dL
Hemoglobin (Hgb) >= 8 g/dl (transfusion acceptable)
HGB ?10 g/dl and not transfusion dependent
Hgb > 9 g/dL
Hgb ?9 g/dL
Within 14 days of study start: Hemoglobin (Hgb) >= 9 g/dL (may transfuse if clinically indicated)
Hemoglobin (Hgb) > 9 g/dL (can be achieved with transfusion)
Hemoglobin (Hgb) >= 8 gm/dL (transfusion independent)
Hemoglobin (Hgb) >= 9.0 g/dL (no red blood cell [RBC] transfusion within past 14 days)\r\n* Hgb >= 8.0 g/dL for patients with anemia associated disease
Hemoglobin (Hgb) >= 9 g/dL (which may be post transfusion)
Hemoglobin (Hgb) >= 9.5 g/dL (transfusion before treatment is allowable if more than 3 days prior to study start)
Hemoglobin (Hgb) >= 9.0 g/dL (90 g/L) without blood transfusion within 7 days
Hemoglobin (Hgb) >= 9 mg/dL (which may be post transfusion)
Hemoglobin (Hgb) >= 9 g/dL may be supported by transfusion and/or hematopoetic growth factors
Hemoglobin (Hgb) >= 9.0 g/dL (transfusion allowed), within 14 days of registration
Hemoglobin (Hgb) >= 8.5 g/dL (transfusion or erythropoietin-like substances not permitted prior to baseline evaluation)
HgB < 9 g/dL
HGB >9.0 g/dL
Hemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion within 1 week of baseline Hgb assessment.
Does the subject have a Hgb ? 10 g/dL?
Hgb > 7.5 g/dl (without transfusion within 7 days)
Hgb ? 9 g/dL
Required prior to infusion of ATLCAR.CD30 cells: Hgb >= 8g/dL without transfusion support over preceding 5 days
Hemoglobin (Hgb) > 10.0 g/dL with no blood transfusion in the past 28 days
Hemoglobin (hgb) ? 8.0 g/dL (may be supported with transfusion)
Hemoglobin (Hgb) >= 9 g/dL (90 g/L); < 9 g/dL (< 90 g/L) is acceptable if Hgb is corrected to >= 9 g/dL (90 g/L) as by growth factor or transfusion prior to PET scan, obtained within 14 days prior to PET scan
